Vicarious Surgical Analyst Ratings
Vicarious Surgical Analyst Ratings
While ratings are subjective and will change, the latest Vicarious Surgical (RBOT) rating was a downgraded with a price target of $9.00 to $0.40. The current price Vicarious Surgical (RBOT) is trading at is $0.38, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 4.17% | Canaccord Genuity | $9 → $0.4 | Downgrades | Buy → Hold |
| 05/31/2023 | 2243.75% | Canaccord Genuity | $12 → $9 | Maintains | Buy |
| 07/18/2022 | 1722.92% | BTIG | $8 → $7 | Maintains | Buy |
| 05/10/2022 | 1202.08% | Piper Sandler | $7 → $5 | Maintains | Neutral |
| 03/04/2022 | 3285.42% | Canaccord Genuity | $15 → $13 | Maintains | Buy |
| 03/04/2022 | 1722.92% | Piper Sandler | $16 → $7 | Downgrades | Overweight → Neutral |
| 01/07/2022 | 4066.67% | Credit Suisse | → $16 | Initiates Coverage On | → Outperform |
| 12/07/2021 | 3806.25% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 11/05/2021 | 3806.25% | Canaccord Genuity | → $15 | Initiates Coverage On | → Buy |
| 10/18/2021 | 3806.25% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 10/07/2021 | 4066.67% | Piper Sandler | → $16 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/14/2023 | 4.17% | Canaccord Genu | 9 美元 → 0.4 美元 | 降级 | 买入 → 持有 |
| 05/31/2023 | 2243.75% | Canaccord Genu | 12 美元 → 9 美元 | 维护 | 买 |
| 07/18/2022 | 1722.92% | BTIG | 8 美元 → 7 美元 | 维护 | 买 |
| 05/10/2022 | 1202.08% | 派珀·桑德勒 | 7 美元 → 5 美元 | 维护 | 中立 |
| 03/04/2022 | 3285.42% | Canaccord Genu | 15 美元 → 13 美元 | 维护 | 买 |
| 03/04/2022 | 1722.92% | 派珀·桑德勒 | 16 美元 → 7 美元 | 降级 | 超重 → 中性 |
| 2022 年 7 月 1 日 | 4066.67% | 瑞士信贷 | → 16 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2021 年 7 月 12 日 | 3806.25% | Cowen & Co. | → 15 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2021 年 5 月 11 日 | 3806.25% | Canaccord Genu | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 2021 年 10 月 18 日 | 3806.25% | BTIG | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 2021 年 7 月 10 日 | 4066.67% | 派珀·桑德勒 | → 16 美元 | 启动覆盖范围开启 | → 超重 |
What is the target price for Vicarious Surgical (RBOT)?
Vicarious Surgical（RBOT）的目标价格是多少？
The latest price target for Vicarious Surgical (NYSE: RBOT) was reported by Canaccord Genuity on November 14, 2023. The analyst firm set a price target for $0.40 expecting RBOT to rise to within 12 months (a possible 4.17% upside). 2 analyst firms have reported ratings in the last year.
Canaccord Genuity于2023年11月14日公布了Vicarious Surgical（纽约证券交易所代码：RBOT）的最新目标股价。该分析公司将目标股价定为0.40美元，预计RBOT将在12个月内升至12个月内（可能上涨4.17％）。去年有2家分析公司公布了评级。
What is the most recent analyst rating for Vicarious Surgical (RBOT)?
分析师对Vicarious Surgical（RBOT）的最新评级是多少？
The latest analyst rating for Vicarious Surgical (NYSE: RBOT) was provided by Canaccord Genuity, and Vicarious Surgical downgraded their hold rating.
Canaccord Genuity提供了Vicarious Surgical（纽约证券交易所代码：RBOT）的最新分析师评级，Vicarious Surgical下调了持有评级。
When is the next analyst rating going to be posted or updated for Vicarious Surgical (RBOT)?
Vicarious Surgical（RBOT）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vicarious Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vicarious Surgical was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Vicarious Surgical的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Vicarious Surgical的最新评级是在2023年11月14日提交的，因此您应该预计下一个评级将在2024年11月14日左右公布。
Is the Analyst Rating Vicarious Surgical (RBOT) correct?
分析师对Vicarious Surgical（RBOT）的评级正确吗？
While ratings are subjective and will change, the latest Vicarious Surgical (RBOT) rating was a downgraded with a price target of $9.00 to $0.40. The current price Vicarious Surgical (RBOT) is trading at is $0.38, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Vicarious Surgical（RBOT）评级已下调，目标股价为9.00美元至0.40美元。Vicarious Surgical（RBOT）目前的交易价格为0.38美元，超出了分析师的预期区间。